Advances in treatment of hyperkalemia in chronic kidney disease. - Wikidata - awgldk - TriplyDB

Advances in treatment of hyperkalemia in chronic kidney disease.

Advances in treatment of hyperkalemia in chronic kidney disease.

http://www.wikidata.org/entity/Q34491934

about

Adverse safety events in patients with Chronic Kidney Disease (CKD).Has RAAS Blockade Reached Its Limits in the Treatment of Diabetic Nephropathy?Drug-resin drug interactions in patients with delayed gastric emptying: What is optimal time window for drug administration?Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.Revisiting RAAS blockade in CKD with newer potassium-binding drugs.Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.Impact of Different Serum Potassium Levels on Postresuscitation Heart Function and Hemodynamics in Patients with Nontraumatic Out-of-Hospital Cardiac Arrest.

P2860

Q30245199-2218AE5D-FDD1-4382-B548-C0E4FFA95241 Q38734501-6CE29DBD-ED7F-404D-88A2-FD9613A6BDB3 Q38778630-20054B3B-E050-4BF9-96E1-72195BB70196 Q42375224-3E5A73B3-80ED-447C-AAFE-EC93F4FBB7F0 Q46622265-A50B13A0-BA51-4C45-8B61-40FD1CCB88F0 Q47669329-DD5F3635-0B40-4152-85BB-F303C629DA7A Q50063221-0B3A466A-9526-4CEA-AE7F-69D1619504E4 Q55119914-7C0126C4-6A97-45D3-BAA8-07A6C1B1F011

P2860

Advances in treatment of hyperkalemia in chronic kidney disease.

http://www.wikidata.org/entity/Q34491934

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Advances in treatment of hyperkalemia in chronic kidney disease.

@ast

Advances in treatment of hyperkalemia in chronic kidney disease.

@en

Advances in treatment of hyperkalemia in chronic kidney disease.

@nl

type

label

Advances in treatment of hyperkalemia in chronic kidney disease.

@ast

Advances in treatment of hyperkalemia in chronic kidney disease.

@en

Advances in treatment of hyperkalemia in chronic kidney disease.

@nl

prefLabel

Advances in treatment of hyperkalemia in chronic kidney disease.

@ast

Advances in treatment of hyperkalemia in chronic kidney disease.

@en

Advances in treatment of hyperkalemia in chronic kidney disease.

@nl

P1433

Q34491934-26851456-5A2A-4233-BE14-1778D6C23F4C

P1476

Q34491934-41B1C489-CB26-45B4-815D-5AA4FCE636D3

P2093

Q34491934-86E36A56-BB08-4954-97FD-D88997193E36

Q34491934-F968C8A4-2CDC-4163-9286-4FCFE3CFA845

P2860

Q34491934-03E190E9-E380-463D-AA03-28045AABFFF4

Q34491934-0BBBC22F-165D-48BC-B2DF-9C9BB0010AF3

Q34491934-0CD79CCC-91C6-442D-96A6-35530924AF05

Q34491934-0DB5C5A7-DF37-4BFE-8FA0-0729B5BDC243

Q34491934-0DE29638-96FA-4AE2-B976-BF113515F425

Q34491934-0EA9DC42-5D32-4509-955B-D76625EC7ADD

Q34491934-13966126-50DB-48FE-942D-3D80D7A03BA5

Q34491934-2072A23D-A01D-4320-AD78-C47795FECAC5

Q34491934-240AC896-AFE8-4CFE-A5AA-58D51E69B920

Q34491934-24DA67FC-9D4D-4D60-B885-35E8DD1EBD05

P304

Q34491934-2C932860-2CC4-4E0A-AC76-079ADAC99D5A

P31

Q34491934-E9CCDF09-71EE-4C82-93DC-7375F06D7A27

P356

Q34491934-0765070B-7F85-4D6E-A639-F3FE62CACA57

P407

Q34491934-45DAFD47-511A-4D24-BC79-C7DD1A334D92

P433

Q34491934-834DF760-4229-45D4-B640-E762287A47EB

P478

Q34491934-5C329D8B-2270-4736-AA43-BD7121A4560D

P50

Q34491934-D38D5563-3A8F-40F2-B8E1-4F915FC296E1

P577

Q34491934-FA78E94A-8141-496D-9D17-7FC94896698B

P5875

Q34491934-F79F306B-2861-4329-BADB-C7CD37207B27

P698

Q34491934-752B9221-D06D-4688-B2F0-CA77BD058FB5

P356

14656566.2015.1083977

P1433

Expert Opinion on Pharmacotherapy

P1476

Advances in treatment of hyperkalemia in chronic kidney disease.

@en

P2093

George L Bakris

http://www.w3.org/2001/XMLSchema#string

Panagiotis I Georgianos

http://www.w3.org/2001/XMLSchema#string

P2860

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?

Hyperkalemia and hyporeninemic hypoaldosteronism

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Trimethoprim-induced hyperkalemia: An analysis of reported cases.

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.

Drug-induced hyperkalemia: old culprits and new offenders.

P304

2205-2215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.1083977

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Pantelis A Sarafidis

P577

2015-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281344025

http://www.w3.org/2001/XMLSchema#string

P698

26330193

http://www.w3.org/2001/XMLSchema#string